Show simple item record

dc.contributor.authorAli Esfandiary
dc.contributor.authorSoudeh Ghafouri-Fard
dc.date.accessioned2017-09-18T10:51:06Z
dc.date.available2017-09-18T10:51:06Z
dc.date.issued2015-01-01
dc.identifier.issn17507448
dc.identifier.urihttp://dsp.sbmu.ac.ir/xmlui/handle/123456789/67476
dc.description.abstract© 2015 Future Medicine Ltd. New York esophageal squamous cell carcinoma 1 (NY-ESO-1) is a known cancer testis gene with exceptional immunogenicity and prevalent expression in many cancer types. These characteristics have made it an appropriate vaccine candidate with the potential application against various malignancies. This article reviews recent knowledge about the NY-ESO-1 biology, function, immunogenicity and expression in cancers as well as and the results of clinical trials with this antigen.
dc.sourceImmunotherapy
dc.subjectcancer-testis antigen
dc.subjectimmunogenicity
dc.subjectimmunotherapy
dc.subjectNY-ESO-1
dc.titleNew York esophageal squamous cell carcinoma-1 and cancer immunotherapy
dc.journal.volume7
dc.journal.issue4
dc.identifier.doi10.2217/imt.15.3
dc.journal.pages411-439
dc.contributor.authorid36521150200
dc.contributor.authorid55387443600
dc.contributor.citation36521150200|60018934|Ali Esfandiary
dc.contributor.citation55387443600|60018934|Soudeh Ghafouri-Fard
dc.contributor.affiliationid60018934
dc.contributor.affiliationid60018934


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record